COVID-19

Li Fung Peck1, Wang Woon Poh1, Adena Theen Lim1

  • 1Vigilance and Compliance Branch, Health Products Regulation Group, Health Sciences Authority, Singapore.

Singapore medical journal
|September 26, 2024
PubMed
概括

接种COVID-19疫苗后的过敏反应很少见,大多数病例发生在mRNA疫苗后不久. 这一审查指导了疫苗接种策略,并增强了对异种疫苗接种安全性的理解.

相关概念视频